PATIENTS | High-grade Glioma

High-grade Glioma

High grade glioma that has come back or spread

Clinical Trial Results
  • Phase III clinical clinical trial studying Theracim use in combination with radiotherapy in adult patients with glioma showed longer survival of 17.76 months compared to patients that received radiotherapy alone with survival of 12.63 months.


*Your doctor may recommend treatment with Theracim based on the stage of your cancer, or your overall health. Please consult with your doctor for more information.

 

High grade glioma that has come back or spread

 

What is Glioma?

Glioma is one of the most common types of tumor that occurs in the brain and spinal cord. Gliomas begin in the glial cell that surround nerve cells and help them function. Glioma has different types based on their location and rate of growth. High grade glioma is a type of glioma that is more agressive and rapidly growing. High grade Glioma has high rate of progression and recurrence compared to low grade glioma.

 

How many people have Glioma?

High grade glioma is fairly rare. It is estimated that the number of adults having high grade glioma in 2015 is 11,882 with number of new cases 3 per 10,000 adults per year.

 

What are the risks for getting glioma?

It is important to know that having 1 or more risk factors does not mean that you will certainly have glioma and some people may get this type of cancer even if they don’t have any risk factors. The risk factors that is associated with glioma:

  • Gender
  • Male slightly has higher risk than females
  • Family history
  • Genetically inhirited tendency
  • Ionising radiation